Tudriqev
vusolimogene oderparepvec-wtpg · Injection, Suspension · Intratumor
No FDA structured label text is available for Tudriqev. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Vusolimogene Oderparepvec in 2 products
Tudriqev NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 83616-106 | Vusolimogene Oderparepvec 1000000 [PFU]/mL Injection, Suspension | Replimune, Inc. | BLA |
| 83616-107 | Vusolimogene Oderparepvec 10000000 [PFU]/mL Injection, Suspension | Replimune, Inc. | BLA |
Frequently asked questions
Who makes Tudriqev?
Tudriqev is listed by 1 labeler in the FDA NDC directory, including Replimune, Inc..